These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7891307)

  • 1. Stereoselective hydrolysis of O-isovaleryl propranolol and its influence on the clearance of propranolol after oral administration.
    Shameem M; Imai T; Yoshigae Y; Sparreboom A; Otagiri M
    J Pharm Sci; 1994 Dec; 83(12):1754-7. PubMed ID: 7891307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Species differences for stereoselective hydrolysis of propranolol prodrugs in plasma and liver.
    Yoshigae Y; Imai T; Horita A; Otagiri M
    Chirality; 1997; 9(7):661-6. PubMed ID: 9366026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantioselective oral bioavailability of 0-isovaleryl propranolol as a potential prodrug of propranolol.
    Shameem M; Imai T; Otagiri M
    J Pharmacobiodyn; 1992 Sep; 15(9):535-40. PubMed ID: 1287187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species differences in the disposition of propranolol prodrugs derived from hydrolase activity in intestinal mucosa.
    Yoshigae Y; Imai T; Aso T; Otagiri M
    Life Sci; 1998; 62(14):1231-41. PubMed ID: 9570338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective hydrolysis of O-acetyl propranolol as prodrug in rat tissue homogenates.
    Takahashi K; Tamagawa S; Haginaka J; Yasuda H; Katagi T; Mizuno N
    J Pharm Sci; 1992 Mar; 81(3):226-7. PubMed ID: 1640358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the ester moiety on stereoselective hydrolysis of several propranolol prodrugs in rat tissues.
    Takahashi K; Tamagawa S; Sakano H; Katagi T; Mizuno N
    Biol Pharm Bull; 1995 Oct; 18(10):1401-4. PubMed ID: 8593445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective hydrolysis and penetration of propranolol prodrugs: in vitro evaluation using hairless mouse skin.
    Ahmed S; Imai T; Otagiri M
    J Pharm Sci; 1995 Jul; 84(7):877-83. PubMed ID: 7562441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in-vitro and in-vivo correlative approach to the evaluation of ester prodrugs to improve oral delivery of propranolol.
    Shameem M; Imai T; Otagiri M
    J Pharm Pharmacol; 1993 Apr; 45(4):246-52. PubMed ID: 8098362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereospecific activity and nature of metabolizing esterases for propranolol prodrug in hairless mouse skin, liver and plasma.
    Ahmed S; Imai T; Yoshigae Y; Otagiri M
    Life Sci; 1997; 61(19):1879-87. PubMed ID: 9364192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective hydrolysis of O-acetyl propranolol as prodrug in human serum.
    Takahashi K; Haginaka J; Tamagawa S; Nishihata T; Yasuda H; Katagi T
    J Pharm Pharmacol; 1990 May; 42(5):356-7. PubMed ID: 1976786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of stereoselective transdermal transport and concurrent cutaneous hydrolysis of several ester prodrugs of propranolol: mechanism of stereoselective permeation.
    Ahmed S; Imai T; Otagiri M
    Pharm Res; 1996 Oct; 13(10):1524-9. PubMed ID: 8899845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of esterases involved in the stereoselective hydrolysis of ester-type prodrugs of propranolol in rat liver and plasma.
    Yoshigae Y; Imai T; Taketani M; Otagiri M
    Chirality; 1999; 11(1):10-3. PubMed ID: 9914648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselectivity in cutaneous hydrolysis and transdermal transport of propranolol prodrug.
    Ahmed S; Imai T; Otagiri M
    Enantiomer; 1997; 2(3-4):181-91. PubMed ID: 9676267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-pass hydrolysis of a propranolol ester derivative in rat small intestine.
    Masaki K; Taketani M; Imai T
    Drug Metab Dispos; 2006 Mar; 34(3):398-404. PubMed ID: 16326813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for the involvement of a pulmonary first-pass effect via carboxylesterase in the disposition of a propranolol ester derivative after intravenous administration.
    Imai T; Yoshigae Y; Hosokawa M; Chiba K; Otagiri M
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1234-42. PubMed ID: 14534358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insight into stereoselective disposition of enantiomers of a potent antithrombotic agent, S002-333 following administration of the racemic compound to mice.
    Bhateria M; Rachumallu R; Yerrabelli S; Saxena AK; Bhatta RS
    Eur J Pharm Sci; 2017 Apr; 101():107-114. PubMed ID: 28189817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species differences in stereoselective hydrolase activity in intestinal mucosa.
    Yoshigae Y; Imai T; Horita A; Matsukane H; Otagiri M
    Pharm Res; 1998 Apr; 15(4):626-31. PubMed ID: 9587961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselective disposition of flurbiprofen from a mutual prodrug with a histamine H2-antagonist to reduce gastrointestinal lesions in the rat.
    Fukuhara A; Imai T; Otagiri M
    Chirality; 1996; 8(7):494-502. PubMed ID: 8970747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoselective disposition of propranolol in rabbits. Role of presystemic organs and dose.
    Marier JF; Pichette V; du Souich P
    Drug Metab Dispos; 1998 Feb; 26(2):164-9. PubMed ID: 9456303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective oral bioavailability of (+/-)-propranolol in the dog. A GC-MS study using a stable isotope technique.
    Walle T; Walle UK
    Res Commun Chem Pathol Pharmacol; 1979 Mar; 23(3):453-64. PubMed ID: 461970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.